Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Wallen

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|December 7, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patientsAngela B Smith, Mathew Raynor, Christopher L Amling, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
The Urologic Clinics of North America|September 29, 2023
Linguistic Differences Based on Gender and Race in Urology Application Personal Statements: A Comparison of 2017 and 2023 ApplicationsEmma C Bethel, Asia N Matthew-Onabanjo, Hannah E Kay, et al.
Cancer|July 13, 2012
Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based studyLixin Song, Ronald C Chen, Jeannette T Bensen, et al.
Urologic Oncology|December 22, 2009
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trialWilliam Y Kim, Young E Whang, Raj S Pruthi, et al.
Scientific Reports|March 4, 2017
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept StudyQingbo Yin, Sheng-Che Hung, Li Wang, et al.
The Journal of Urology|July 30, 2014
Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimateDavid C Johnson, Josip Vukina, Angela B Smith, et al.
BJU International|September 29, 2012
Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancerRonald C Chen, Julian G Rosenman, Leroy G Hoffman, et al.
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
The Journal of Urology|February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinomaThomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|December 7, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patientsAngela B Smith, Mathew Raynor, Christopher L Amling, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
The Urologic Clinics of North America|September 29, 2023
Linguistic Differences Based on Gender and Race in Urology Application Personal Statements: A Comparison of 2017 and 2023 ApplicationsEmma C Bethel, Asia N Matthew-Onabanjo, Hannah E Kay, et al.
Cancer|July 13, 2012
Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based studyLixin Song, Ronald C Chen, Jeannette T Bensen, et al.
Urologic Oncology|December 22, 2009
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trialWilliam Y Kim, Young E Whang, Raj S Pruthi, et al.
Scientific Reports|March 4, 2017
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept StudyQingbo Yin, Sheng-Che Hung, Li Wang, et al.
The Journal of Urology|July 30, 2014
Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimateDavid C Johnson, Josip Vukina, Angela B Smith, et al.
BJU International|September 29, 2012
Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancerRonald C Chen, Julian G Rosenman, Leroy G Hoffman, et al.
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
The Journal of Urology|February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinomaThomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
Pageof 11